Arphra/Issuer/VRTX

VRTX

Vertex Pharmaceuticals Incorporated

HealthcareBiotechnologyUSUSD

$447.54

+0.50%Live · FMPMay 29, 2026

AI Brief

Market cap

$113.59B

52w range

362.50 – 507.92

P / E

—

EPS

—

Volume

1.89M

Revenue · FY

$12.07B

+9.57% YoY

Total filings

Last ~200

YTD

2026

8-Ks · 12mo

Current reports

Last filing

—

AI · Disclosure analysis

Arphra AI

Click Analyze filings to have Arphra AI review the last 80 SEC filings for VRTX and return: a one-paragraph summary of recent disclosure activity, 3-5 thematic patterns, 3-5 notable individual filings worth flagging, and 2-3 watch items.

M&A activity

1DB · FMP /mergers-acquisitions

Whole-company transactions where VRTX is acquirer or target.

Date	Role	Counterparty	Filing
May 23, 2001	Acquirer	Aurora	SEC →

No filings in last 5 years.

Form-type mix

No data.

All 8-K · Current reports 10-K · 10-Q Proxy & ownership Registration Other

0 filingsDB · sec_filings

Filed	Accepted	Form	Description	Link
No filings in this group.